Content
User login
Enter your username and password here in order to log in on the website:
- Contact us
- About us
- Disclaimer
Dustri-Verlag
Volume 43, No. 12/2005(December)
|
The use of the online-version will be charged with an extra fee (additional to the subscription of the print-version). The service can be used until December 31st of the year of subscription. |
|
| Full Issue Price: 26.00$ |  |
Index
Contents for Volume 43
3
28$
Index
Author index
9
12$
Index
Subject index
11
12$
Pharmacodynamics
The ability of statins to protect low density lipoprotein from oxidation in hypercholesterolemic patients
551
32$
Case report
Acute pancreatitis associated with omeprazole
558
20$
Pharmacokinetics
The pharmacokinetics of zinc from zinc gluconate: a comparison with zinc oxide in healthy men
562
20$
Extended Abstracts
Annual Meeting of the Working Group for Pharmacology in Oncology and Hematology (APOH) of the Central European Society for Anticancer Drug Research (CESAR) during the Symposium ?Novel Approaches for the Discover
566
8$
Extended Abstracts
Pemetrexed: mRNA expression of the target genes TS, GARFT and DHFR correlates with the in vitro chemosensitivity of human solid tumors
567
16$
Extended Abstracts
In vitro investigation on the selectin binding mechanisms in tumor cell metastasis and their inhibition by heparin
570
16$
Extended Abstracts
Individual variation in factors affecting the steps between dose application and effects of antineoplastic agents
573
12$
Extended Abstracts
Rational development of oxaliplatin analogues ? synthesis and preliminary structure-activity relationships
575
12$
Extended Abstracts
Current pharmacogenetics in colorectal cancer ? do they have an impact on our clinical treatment strategies?
577
12$
Extended Abstracts
Identification of new genes involved in cisplatin resistance and their expression profile in 18 human tumor cell lines
579
12$
Extended Abstracts
Targeting of immunoliposomes to endothelial cells expressing VCAM: a future strategy in cancer therapy
581
12$
Extended Abstracts
Interactions of a novel ruthenium-based anticancer drug (KP1019 or FFC14a) with serum proteins ? significance for the patient
583
16$
Extended Abstracts
A new oxygen-enriched solution enables human tumor tissue transport without cell devitalization
586
12$
Extended Abstracts
Pharmacokinetics (PK) of a liposomal encapsulated fraction containing doxorubicin and of doxorubicin released from the liposomal capsule after intravenous infusion of Caelyx?/Doxil
588
12$
Extended Abstracts
Early results from a phase I study on orally administered tris(8-quinolinolato)gallium(III) (FFC11, KP46) in patients with solid tumors ? a CESAR study (Central European Society for Anticancer Drug Research ? EW
590
12$
Extended Abstracts
Molecular targets of indirubins
592
16$
Extended Abstracts
KP1019 (FFC14A) from bench to bedside: preclinical and early clinical development ? an overview
595
12$
Extended Abstracts
Expression profile of copper transporters in sensitive and cisplatin/oxaliplatin-resistant tumor cell lines
597
12$
Extended Abstracts
Proteomic analysis of chemoresistance to 5-fluorouracil in colon cancer in vitro
599
12$
Extended Abstracts
Flat dose (175 mg/weekly) paclitaxel: pharmacokinetics and clinical implications
601
12$
Extended Abstracts
Enzastaurin and pemetrexed exert synergistic antitumor activity in thyroid cancer cell lines in vitro
603
12$
Extended Abstracts
Contrast-enhanced MR imaging in the indirect monitoring of drug release from an interstitial depot
605
12$
Extended Abstracts
Searching for cellular targets of novel pteridines downstream of cAMP PDE inhibition
607
12$
